As cancer incidence continues to rise worldwide, healthcare providers need diagnostic solutions that deliver greater confidence and precision. Abbott's oncology portfolio is designed to support clinicians and laboratories with reliable biomarker testing that helps guide clinical decisions across the cancer care continuum.
It's more than a test.
It's informed clinical decision making.
For in vitro diagnostic use.
Helping Guide Decisions Throughout the Cancer Journey
Enhancing Assay Performance Through Algorithm-Based Testing
With one out of every two people expected to get cancer during their lifetime there is a clear need to optimize diagnostic solutions to tackle key challenges in oncology management.1
Modern oncology increasingly utilizes advanced testing approaches that integrate multiple biomarkers into a single result using sophisticated algorithms. Known as Multianalyte Assays with Algorithmic Analysis (MAAAs), these tests may enhance overall clinical performance and provide more comprehensive insights than individual biomarkers alone.
ASSAYS ENGINEERED TO PROVIDE RELIABLE ASSISTANCE IN CANCER MANAGEMENT
Abbott offers a wide variety of assays to assist in the risk-stratification, diagnosis and management for many types of cancers including, colon, liver, ovarian, breast, pancreatic, testicular, gastrointestinal, lung and prostate cancer.
The oncology solutions from Abbott can help you reduce laboratory operational costs while maintaining the quality standards necessary to have a meaningful positive impact to the quality and cost of health care.
Visit our individual disease state pages to discover more about biomarker solutions
Core Laboratory Menu and Systems
| Cancer |
| AFP |
| CA 125 II |
| CA 15-3 |
| CA 19-9 (CA 19-9 XR) |
| CA 72-4* |
| CEA |
| CYFRA 21-1 |
| HE-4 (ROMA) |
| Immunoglobulin A (IgA) |
| Immunoglobulin E (IgE) |
| Immunoglobulin G (IgG) |
| Immunoglobulin M (IgM) |
| Human Kappa (κ) FreeLight Chain |
| Human Lambda (λ) Free Light Chain |
| NSE |
| Pepsinogen I |
| Pepsinogen II |
| PIVKA-II |
| ProGRP |
| PSA, Free |
| PSA, Total |
| SCC |
*In development. Not commercially available.
Login or register for a new account on the Lab Central customer portal. Here you can view assay specific package inserts for intended use, important safety information and manage your personalized lab metrics.
A unified approach
Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.
References
- NHS. 2022. Cancer Overview. Available at: https://www.nhs.uk/conditions/cancer/. Last accessed: 31 July 2023.